期刊文献+

人类表皮生长因子受体-2高亲和力模拟肽对卵巢癌细胞SKOV3生长的抑制作用

Effect of peptide mimic on ovarian cancer cell line in vitro
原文传递
导出
摘要 目的 研究人类表皮生长因子受体-2(Her-2)高亲和力模拟肽(YCFPDEEGACY)对卵巢癌细胞株SKOV3增殖的影响.方法 化学合成模拟多肽,用MTT法检测合成多肽对SKOV3细胞株体外生长的抑制作用.结果 含模拟肽成分组与阴性对照组比较(t≥2.896,P〈0.05) 单纯EGF组与相应EGF和模拟肽共同作用组比较(f≥3.355,P〈0.05),显示模拟肽对Her-2高表达的卵巢癌细胞株SKOV3的体外生长有明显抑制作用,对Her-2低表达的乳腺癌细胞株MDA-MB-231无明显抑制作用.结论 Her-2高亲和力模拟多肽可与Her-2高表达的卵巢癌细胞特异结合并能明显抑制其在体外的生长,为卵巢癌靶向生物治疗提供依据. Objective To study the inhibition of peptide mimic(YCFPDEEGACY)on ovarian cancer cell line positive for Her-2 expression.Methods Peptide mimic was synthesized through chemical ways,and the inhibition effect of peptide mimic on SKOV3,MDA-MB-231 cell lines expressing Her-2 were evaluated with MTr assay. Results Between mimic peptide groups and negative control,there Was statistical significance in mean of A490(t≥2.896,P〈0.05).Different dose EGF group compared with its added mimic peptide group,there was also statistical significance in mean of A490(t≥13.355,P〈0.05).Cell proliferation assay showed that peptide mimic could inhibit cell proliferation of SKOV3. Conclusion Peptide can specifically bind to ovarian cancer cell line SKOV3 that overexpress Her-2 and inhibit its proliferation.
出处 《肿瘤研究与临床》 CAS 2010年第6期374-377,共4页 Cancer Research and Clinic
关键词 受体 erbB-2 模拟肽 卵巢肿瘤 生长抑制物 Receptor,erbB-2 Peptide mimic Ovarian neoplasms Growth inhibitors
  • 相关文献

参考文献10

  • 1Chiang CT,Way TD,Lin JIL et al.Sensitizing HER2-overexpressing cancer cellsto luteolin-induced apoptesis through suppressing p21(wAF1/CIP1)expression with rapamycin.Mol Cancer Ther,2007,6:2127-2138.
  • 2Peru SC,Shukla GS,Armstrong AL,et al.Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cells.Int J Callcer,2004,111:951-960.
  • 3Berezov A,Chen J,Liu Q,et al.Disabling receptor ensembles with rationally designed interface peptidomimetics.J Biol Chera,2002,277:28330-28339.
  • 4Hansen MB,Nielsen SE,Berg KJ.Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.Immunol Meth,1989,1 19:203-210.
  • 5Holbro T,Beerli RR,Maurer F,et al.The ErbB2/ErbB3 heterodimer functions as an oncogenic unit:ErbB2 requires ErbB3 to drive breast tumor cell proliferation.Proe Natl Acad Sci U S A,2003,100:8933-8938.
  • 6Gadella TW,Jovin TM.Oligomerization of epidermal growth factor receptors on A43 1 cells studied by time-resolved fluorescence imaging microscopy.A stereochemical model for tyrosine kinase receptor activation.J Cell Biol,1995,129:1543-1558.
  • 7Naismith JH,Brandhuber BJ,Devine TQ,et al.Seeing double:crystal structures of the type I TNF receptor.J Mol Recognit,1996,9:113-117.
  • 8Cianfrocca M,Goldstein L J.Prognostic and predictive factors in early-stage breast cancer.Oncologist,2004.9:606-616.
  • 9焦德,任国胜.HER 2基因在乳腺癌中的研究进展[J].国外医学(外科学分册),2005,32(5):374-378. 被引量:3
  • 10Albanell J,Codony J,Rovira A,et al.Mechanism of action of anti-HER2 monoclonal antibodies:scientific update on trastuzumab and 2C4.Adv Exp Med Biol,2003,532:253-268.

二级参考文献2

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部